ImmunoPrecise Antibodies Ltd. Annual Research And Development Expense in CAD from 2019 to 2023

Taxonomy & unit
ifrs-full: CAD
Summary
ImmunoPrecise Antibodies Ltd. quarterly/annual Research And Development Expense history and growth rate from 2019 to 2023.
  • ImmunoPrecise Antibodies Ltd. Research And Development Expense for the quarter ending October 31, 2024 was CA$1.16M, a 38.3% increase year-over-year.
  • ImmunoPrecise Antibodies Ltd. Research And Development Expense for the twelve months ending October 31, 2024 was CA$5.06M.
  • ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2023 was CA$4.04M, a 71.3% decline from 2022.
  • ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2022 was CA$14.1M, a 84% increase from 2021.
  • ImmunoPrecise Antibodies Ltd. annual Research And Development Expense for 2021 was CA$7.66M, a 288% increase from 2020.
Research And Development Expense, Trailing 12 Months (CAD)
Research And Development Expense, Annual (CAD)
Research And Development Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 4.04M -10.1M -71.3% May 1, 2023 Apr 30, 2024 20-F 2024-07-29
2022 14.1M +6.44M +84% May 1, 2022 Apr 30, 2023 20-F 2024-07-29
2021 7.66M +5.69M +288% May 1, 2021 Apr 30, 2022 20-F 2024-07-29
2020 1.97M +1.53M +343% May 1, 2020 Apr 30, 2021 40-F 2022-07-29
2019 446K May 1, 2019 Apr 30, 2020 40-F/A 2021-09-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.